Cargando…
Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis
Lung cancer is the leading cause of death in the United States, with non-small cell lung cancers (NSCLC) accounting for 85% of all cases. By analyzing the expression profile of the pro-apoptotic and anti-apoptotic proteins, we have assigned NSCLCs into two distinct groups. While single agent treatme...
Autores principales: | Shen, Qi, Li, Jun, Mai, Junhua, Zhang, Zhe, Fisher, Andrew, Wu, Xiaoyan, Li, Zhaoqi, Ramirez, Maricela R., Chen, Shuqing, Shen, Haifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155218/ https://www.ncbi.nlm.nih.gov/pubmed/30250075 http://dx.doi.org/10.1038/s41419-018-1040-9 |
Ejemplares similares
-
Regulation of apoptosis by an intrinsically disordered region of Bcl-xL
por: Follis, Ariele Viacava, et al.
Publicado: (2018) -
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
por: Baranski, Zuzanna, et al.
Publicado: (2015) -
Bcl-xL in neuroprotection and plasticity
por: Jonas, Elizabeth A., et al.
Publicado: (2014) -
Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
por: Yoshimine, S, et al.
Publicado: (2013) -
Nutritional Regulators of Bcl-xL in the Brain
por: Park, Han-A, et al.
Publicado: (2018)